Dyne Therapeutics (DYN) PT Lowered to $30 at RBC Capital
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $26.38 +0.80%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on Dyne Therapeutics (NASDAQ: DYN) to $30.00 (from $36.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Hyperion DeFi, Inc. (HYPD) PT Raised to $7.10 at Cantor Fitzgerald
- CAVA Group Inc (CAVA) PT Lowered to $75 at DA Davidson Following Q2 Results
- Axos Financial (AX) PT Raised to $120 at Benchmark
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
